Browse by Uncontrolled Keywords
Number of items: 3.
2007
Schmidt, MK;
Reincke, S;
Broeks, A;
Braaf, LM;
Hogervorst, FBL;
Tollenaar, R;
Johnson, N;
Fletcher, O;
Peto, J;
Tommiska, J;
+8 more...
Blomqvist, C;
Nevanlinna, HA;
Healey, CS;
Dunning, AM;
Pharoah, PDP;
Easton, DF;
Doork, T;
Van't Veer, LJ;
(2007)
Do MDM2 SNP309 and TP53 R72P interact in breast cancer susceptibility? A large pooled series from the breast cancer association consortium.
Cancer research, 67 (19).
pp. 9584-9590.
ISSN 0008-5472
DOI: https://doi.org/10.1158/0008-5472.CAN-07-0738
Full text not available from this repository.
2004
Coombes, RC;
Hall, E;
Gibson, LJ;
Paridaens, R;
Jassem, J;
Delozier, T;
Jones, SE;
Alvarez, I;
Bertelli, G;
Ortmann, O;
+17 more...
Coates, AS;
Bajetta, E;
Dodwell, D;
Coleman, RE;
Fallowfield, LJ;
Mickiewicz, E;
Andersen, J;
Lønning, PE;
Cocconi, G;
Stewart, A;
Stuart, N;
Snowdon, CF;
Carpentieri, M;
Massimini, G;
Bliss, JM;
van de Velde, C;
Intergroup Exemestane Study;
(2004)
A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer.
The New England journal of medicine, 350 (11).
pp. 1081-92.
ISSN 0028-4793
DOI: https://doi.org/10.1056/NEJMoa040331
2001
Donnellan, R;
Kleinschmidt, I;
Chetty, R;
(2001)
Cyclin E immunoexpression in breast ductal carcinoma: pathologic correlations and prognostic implications.
Human pathology, 32 (1).
pp. 89-94.
ISSN 0046-8177
DOI: https://doi.org/10.1053/hupa.2001.21141
Full text not available from this repository.